Overintervention has always been a controversial problem in cancer intervention, and it is prevalent in cancer intervention.
As early as 2014, CCTV clearly pointed out in interviews with cancer patients that excessive intervention in cancer will only increase the suffering of patients.
What are the manifestations of over-intervention?
One is to blindly require or encourage the expansion of the scope of surgery. This will lead to the removal of many normal tissues for no reason, every tissue in the human body is irreplaceable, and excessive resection will only bring unnecessary damage to the patient's body, reduce the quality of life, and also affect the recovery process.
The second is the blind pursuit of high-dose and multi-course radiotherapy and chemotherapy programs. Many patients and their families think that increasing the dose and cycle of radiotherapy and chemotherapy can more completely eliminate the residual cancer cells, and some even transfer to other hospitals to increase the course of treatment after the normal course of treatment, the consequences of this overcorrection are very serious, excessive radiotherapy and chemotherapy not only make patients suffer unnecessary torture and pain, but also more likely to accelerate the metastasis and recurrence of cancer, and even accelerate the death of patients.
The third is the blind pursuit of imported medicines, new technologies, and even superstitious home remedies from unknown sources. Although many new technologies and drugs work well, they are not suitable for all cancer patients, and whether they are suitable or not depends on the judgment of professional doctors. As for superstitious home remedies, not to mention, they will only bring more serious harm to patients.
After 17 courses of NK cell supplementation, the survival time of advanced liver cancer exceeded 48 months
A trial report in the well-known foreign journal "Oncotargets and Therapy" showed that NK cell intervention significantly reduced the tumor of patients with advanced liver cancer, from only 3 months to more than 4 years of survival. (Case report: 17 courses of NK cell supplementation, multiple tumors shrunk, and the survival time exceeded 48 months)
In June 2016, a 59-year-old man with advanced diffuse hepatocellular carcinoma (HCC) underwent peritoneal puncture surgery and drug supplementation (recombinant human endostatin, cisplatin, loplatin) under general anesthesia between October and December of the same year; In March 2017, he underwent intraperitoneal perfusion (recombinant human endostatin).
From March 2017 to July 2018, he completed 17 courses of NK cell intervention. Each course of treatment was supplemented once a month and for two consecutive days, and the patient did not receive other interventions during the NK cell intervention. After NK cell supplementation, patients benefited significantly.
After 6 sessions, the patient's pleural effusion and ascites were significantly reduced. The patient has remained in this state since the end of the intervention. In addition, patients repeated the intervention cycle several times to consolidate the effect of the intervention, and after 17 courses of NK cell intervention, the size of multiple tumors in the right liver lobe decreased.
It is worth mentioning that the patient's survival time > 48 months, which is more than 4 years!
Nowadays, there are many intervention options that can benefit cancer patients, and advances in medical care are gradually making cancer a manageable chronic disease rather than a terminal disease. On the premise of fully understanding our own condition, we should communicate with doctors, weigh the pros and cons, and choose a reasonable and scientific intervention plan, including cutting-edge immune cell intervention technology, to improve the quality of life of patients, reduce the risk of recurrence and metastasis, and then prolong survival as much as possible.